Aspergillus fumigatus and multiple other Aspergillus species cause a wide range of lung infections, collectively termed aspergillosis. Aspergilli are ubiquitous in environment with healthy immune systems routinely eliminating inhaled conidia, however, Aspergilli can become an opportunistic pathogen in immune-compromised patients. The aspergillosis mortality rate and emergence of drug-resistance reveals an urgent need to identify novel targets. Secreted and cell membrane proteins play a critical role in fungal-host interactions and pathogenesis. Using a computational pipeline integrating data from high-throughput experiments and bioinformatic predictions, we have identified secreted and cell membrane proteins in ten Aspergillus species known to cause aspergillosis. Small secreted and effector-like proteins similar to agents of fungal-plant pathogenesis were also identified within each secretome. A comparison with humans revealed that at least 70% of Aspergillus secretomes has no sequence similarity with the human proteome. An analysis of antigenic qualities of Aspergillus proteins revealed that the secretome is significantly more antigenic than cell membrane proteins or the complete proteome.
Introduction
terreus 30, 59, 60 , A. nidulans 58, [61] [62] [63] [64] [65] and A. oryzae 57, [66] [67] [68] [69] [70] [71] [72] [73] , respectively (Methods; Supplementary   Table S1 ).
Computational pipeline for fungal secretome prediction
High-throughput experimental studies that identify secretome can be limited by the detection technology used or the small set of experimental conditions assessed. Such secretomic studies mainly focus on identifying the proteins secreted to the extracellular matrix and not on proteins incorporated into the cell membrane by the eukaryotic secretion pathway. Since cell membrane proteins, including integral proteins, are localized on the cell surface, they can serve as excellent targets for drugs or vaccines. Here we have designed a computational pipeline to predict both secreted extracellular and cell membrane proteins in fungi. Importantly, our pipeline also incorporates and prioritizes available information on the experimentally identified secreted and cell membrane proteins. Furthermore, our pipeline subdivides the secretome into two subsets, proteins that follow the classical secretion pathway through the endoplasmic reticulum (ER) and those that exit the cell boundary through a non-classical secretion pathway. Figure 1 contains a flowchart of our prediction pipeline.
Our pipeline starts from the complete proteome of a fungus. Initially, intracellular proteins based on UniProt 19 annotation with experimental evidence were removed from later analysis. Subsequently, the remaining proteins without experimental evidence for intracellular localization were classified into two mutually exclusive categories. The first category contained secreted or cell membrane proteins with experimental evidence from compiled list of high-throughput proteomic studies or UniProt, and the second category contained proteins without experimental evidence of secretion to the extracellular matrix or localization to the cell membrane.
The first category of proteins with experimental evidence were assessed for signal peptide, Glycosylphosphatidylinositol (GPI) anchor or TM domain, confirming passage through the classical pathway (Branch A in Figure 1 ; Methods). Next, the presence of GPI anchor or TM domain in proteins sorted by classical pathway is used to separate the cell membrane from extracellular proteins. Next, the proteins without a signal peptide, GPI anchor and TM domain but with experimental evidence of secretion to extracellular matrix were assigned to nonclassical pathway (Branch A in Figure 1 ).
The second category of proteins without experimental evidence were screened based on predictions from computational tools as follows. Firstly, the second category of proteins were screened for signal peptide, GPI anchor or TM domain, suggesting translocation into the ER and passage through classical pathway. Next, the proteins predicted to have a signal peptide, GPI anchor or TM domain but also with an ER retention signal were removed from later analysis (Branch B in Figure 1 ; Methods). Next, the proteins predicted to have GPI anchor or TM domain along with subcellular localization as cell membrane were classified as cell membrane proteins, and proteins without GPI anchor and TM domain along with subcellular localization as extracellular were classified as extracellular proteins sorted by classical pathway (Branch B in Figure 1 ).
Lastly, the subset of the second category of proteins which lack signal peptide, GPI anchor and TM domain, were assessed for presence of orthologs in the list of secreted proteins with experimental evidence in other fungi (Methods; Branch C in Figure 1 ). Next, those proteins in the subset which are orthologs of experimentally identified secreted proteins in other fungi were assessed for an ER retention signal and their predicted subcellular localization, and those without an ER retention signal and predicted subcellular localization as extracellular were classified as extracellular proteins secreted through a non-classical secretion pathway (Branch C in Figure 1 ). To our knowledge, SecretomeP 74,75 is the only prediction tool for non-classical secretion pathway, however, SecretomeP 74,75 is designed for bacteria and mammals and not for fungi. Still FSD 16 has employed SecretomeP 74, 75 to predict approximately 40% of the proteome 6 in several fungi as secreted via a non-classical secretion pathway which clearly is an overestimation. For example, FSD predicts 3546 A. fumigatus proteins, which is 35% of the proteome, to be secreted by a non-classical pathway. Thus, we employ here an alternate ortholog-based method to predict proteins secreted via a non-classical pathway.
Using this pipeline, we identified comprehensive sets of secreted and cell membrane proteins in ten Aspergillus species causing aspergillosis; Figure 2 displays the size of each set, Supplementary Table S2 lists the proteins in each set, and Supplementary Table S3 gives detailed annotations such as protein family, conserved domain, carbohydrate-binding modules and gene ontology (GO) terms for proteins in each set. Additionally, our pipeline provides a refined view of the protein sorting mechanisms in Aspergillus species by classifying secreted proteins into classical and non-classical pathway. In A. fumigatus, the predicted set of secreted and cell membrane proteins contained 662 and 1129 proteins, respectively, representing 6.7% and 11.5% of the proteome. Among the 662 proteins in A. fumigatus secretome, 64 were predicted to be secreted by a non-classical pathway. Figures 3 shows the significantly enriched GO biological processes in the predicted secretome and cell membrane proteins of A. fumigatus.
Within the A. fumigatus secretome, 598 proteins sorted by classical pathway have GO annotations related to carbohydrate metabolism, proteolysis and cell wall modification, and 64 proteins secreted by a non-classical pathway have GO annotations related to carbohydrate metabolism, response to reactive oxygen species (ROS), alcohol degradation and gliotoxin metabolism. Many of the GO processes annotated with A. fumigatus proteins secreted by nonclassical pathway are associated with virulence. Especially, gliotoxin has immunosuppressive properties and is suspected to be an important virulence factor in Aspergillus pathogenesis [76] [77] [78] [79] .
This suggests that non-classical pathways may be important for the secretion of virulence factors in A. fumigatus.
Small secreted and effector-like proteins
Within the fungal secretome, small secreted proteins (SSPs) with sequence length less than 300 amino acids have been widely studied for their role in fungal-plant pathogenesis 20, 21 . A few of the SSPs have been found to act as effectors that play a central role in establishing plant infection 22, 23 . Typically, fungal effector proteins do not share conserved domains which renders effector prediction a challenge 80, 81 . Still, fungal effectors often share certain sequence 7 characteristics such as size, cysteine content, or small motifs identified in fungi and oomycetes 80, 81 . A recent study 82 compared the SSPs across eight Aspergillus species focusing on plant biomass degradation. However, the role of SSPs and effector-like proteins in fungal-human pathogenesis, including aspergillosis, remains largely unanswered 83 . Thus, we have identified SSPs and effector-like proteins within the secretomes of Aspergillus species to enable discovery of potential virulence proteins ( Supplementary Table S4 ). Note that effector-like proteins of Aspergillus species were predicted based on EffectorP 81 predictions or cysteine content of SSPs (Methods). We found that SSPs and effector-like proteins account for more than 30% and 10%, respectively, of the secretomes in Aspergillus species ( Figure 2 
Upregulated secretome and cell membrane proteins in A. fumigatus during pathogenesis
To place the identified secretome and cell membrane proteins of A. fumigatus within the context of aspergillosis, we overlaid a previously published gene expression dataset 26 .
Significantly differentially expressed and upregulated genes coding for secreted and cell membrane proteins may suggest a vital path or key towards pathogenesis. Note that several gene expression studies in A. fumigatus have been published on various cell cultures. However, due to the difficulty in obtaining sufficient high-quality RNA directly from sites of infection, gene expression studies of A. fumigatus in live animal models are limited. Thus, we selected for our analysis a published microarray dataset 26 from a murine lung model which provided one of the first transcriptional snapshots of A. fumigatus during initiation of mammalian infection.
In this dataset 26 
Conservation of secretome across Aspergillus species
The ability of multiple Aspergilli to switch into an opportunistic pathogen may be derived from conserved proteins. Conversely, species-specific proteins may explain the observed differences in virulence between Aspergilli. To determine the unique and conserved proteins across Aspergillus species, OrthoMCL 84 was used to identify orthologs between the proteins of nine Aspergillus species. As A. ustus has an incomplete genome, it was omitted from this comparative analysis. 
Comparison with the human proteome
Ideally, antifungals should target fungi-specific proteins to prevent cross-toxicity with human proteins. In order to identify fungi-specific druggable targets, BLASTP with an E-value 9 cut-off of ≤ 1e-3 was used to identify Aspergillus proteins without a close homolog in the human proteome. We find that more than 70% of the secretomes in Aspergillus species is unique, without a homolog in humans ( Figure 5 ). In contrast to the secretomes, the cell membrane fraction or whole proteome of Aspergillus species have a much lower fraction of unique proteins without a homolog in humans ( Figure 5 ). Specifically, A. fumigatus has 71% of its secretome and 52% of its cell membrane proteins without a homolog to humans, and this offers a significant candidate set that may be screened for druggability or biomarker design. The striking difference between conservation of whole proteome and secretome of Aspergillus species in humans can likely be attributed to the large presence of proteins associated with plant cell wall degradation 85 in the Aspergillus secretomes.
Antigenicity of the secretome
Protein vaccines have been proven successful for several invasive fungi 86, 87, 88 . For example, vaccination with the A. fumigatus allergen Aspf3 protected immunosuppressed mice from developing aspergillosis 89 . One measure of clinical importance is the number of potential antigenic regions on a protein. The more antigenic a protein the more likely it can be used as a biomarker, targeted for immunotherapy, or used in vaccinations. To help prioritize Aspergillus proteins, the Abundance of Antigenic Regions (AAR) 24 value of proteins was calculated using two methods, Kolaskar-Tongaonkar 90 and BepiPred 2.0 91 (Methods). The lower the AAR value the more antigenic the protein 24 . Interestingly, in each Aspergillus species, the average AAR of the secretome is always significantly lower than cell membrane proteins ( Figure 6 ; Methods). Furthermore, the average AAR of the secretome and cell membrane proteins was also found to be significantly lower (p < 0.001) and significantly higher (p < 0.001), respectively, in comparison to the average AAR of randomly chosen, equally sized sets of proteins from the whole proteome (Methods). Note that similar observations on relative AAR of secretome and cell membrane proteins were also recently made in tapeworms, Taenia solium 24 and Echinococcus multilocularis 92 , and in bacterium Mycobacterium tuberculosis 93 . Thus, secreted proteins are likely to be more antigenic than cell membrane proteins, and while choosing candidates for vaccine development, the secretome may provide a more antigenic landscape than cell membrane proteins. While a comparison of the AAR of secretome and cell membrane proteins in Aspergillus species provides insight on relative virulence within a proteome, no significant difference in the average AAR could be detected between A. fumigatus and the Aspergillus cohort.
Druggability analysis of A. fumigatus secretome and cell membrane proteins upregulated during pathogenesis
Beyond immune-therapy, biomarker, and vaccine development, drugs are often the main line of defence against aspergillosis. However, the current arsenal to combat aspergillosis is limited to 7 approved drugs. Furthermore, resistance to these few drugs is an ever-emerging threat 14 . Particularly, fungi are adept at developing resistance to drugs that act on intracellular proteins by pumping them back out into the extracellular matrix through efflux pumps. However, targeting of secreted proteins and cell membrane proteins could circumvent this specific defence mechanism altogether. To expedite drug discovery pipeline, DrugBank 25 provides a database of known drugs and their targets, many of which have been successfully repurposed against similar protein targets in different pathogens 94 .
Firstly, the list of 4063 known drug target proteins was compiled from DrugBank 25 .
Secondly, the secreted and cell membrane proteins in Aspergillus species with no close human homologs based on BLASTP with an E-value cut-off of ≤ 1e-3 were determined. Thereafter, secreted and cell membrane proteins in Aspergillus species with no close human homologs but with sequence similarity to known drug target proteins based on BLASTP E-value cut-off of ≤ 1e-5 were determined ( Supplementary Table S5 ). In A. fumigatus, 50 secreted and 16 cell membrane proteins were found to have sequence similarity with known drug target proteins.
Subsequently, we focused on upregulated genes in a transcriptome dataset 26 for A. fumigatus during pathogenesis to identify potential target proteins for drug repurposing.
In the transcriptome dataset 26 for A. fumigatus, we found 97 secreted and 101 cell membrane proteins with no close human homologs to be significantly upregulated over 2-fold during pathogenesis. These 97 secreted and 101 cell membrane proteins in A. fumigatus were searched against known target protein sequences for sequence similarity to known drug targets.
Seven secreted proteins, Afu7g06140, Afu8g01670, Afu2g15160, Afu5g14380, Afu6g09740, Afu3g00610 and Afu1g09900, of which three proteins, Afu8g01670, Afu6g09740 and Afu1g09900, are secreted via non-classical pathways, and one membrane protein, Afu6g03570, had a significant hit to known drug target proteins. After establishing the sequence similarity between A. fumigatus proteins and known drug target proteins, structural similarity was probed (Methods). Experimentally identified protein structure was available only for Afu6g09740, and it was downloaded from the protein data bank 95 (PDB). As good-quality structure model was also unavailable for Afu2g15160, it was omitted from later analysis. For the remaining five secreted proteins and one cell membrane protein, structure models were obtained from ModBase 96 and SWISS-MODEL 97 . Thereafter, the compiled protein structures were compared to their DrugBank counterparts for structural similarity. Four secreted proteins, Afu5g14380, Afu8g01670, Afu1g09900 and Afu6g09740, had significant structural similarity with TM scores greater than 0.8 and root-mean-square deviation (RMSD) values lower than 3Å 2 (Table 1 ; Methods). One of the proteins, Afu8g01670, is a putative bifunctional catalase-peroxidase which has been shown to be involved in virulence 98 . Afu5g14380 is an α-glucuronidase involved in the hydrolysis of xylan. Afu1g09900 is involved in degradation of arabinoxylan. Afu6g09740 is a thioredoxin reductase which is a part of the gene cluster involved in biosynthesis of gliotoxin in A. fumigatus, and its knockout has been shown to affect the oxidation of gliotoxin and render the fungi hypersensitive to exogenous gliotoxin 99 . Afu6g09740 was also found to be immunogenic in humans and a potential biomarker of aspergillosis 100 .
Given the sequence and structural similarity of these four A. fumigatus proteins, Afu5g14380, Afu8g01670, Afu1g09900 and Afu6g09740, to known drug targets, the proteins were subsequently tested whether they could bind to their respective drugs ( Table 2 ; Methods).
The four proteins were analyzed for the presence of ligand binding pockets using metaPocket 2.0 101 . For each of the four proteins, the top three ligand binding pockets were tested for ligand binding affinity using AutoDock Vina 102 . Table 2 lists the four Aspergillus proteins, the corresponding target proteins in DrugBank with both sequence and structural similarity, their reported approved or experimental drugs, and the binding affinity of each drug to the ligand pockets. Using AutoDock Vina 102 , it was found that most of the identified drug candidates have an affinity value of ≤ -5.0 kcal/mol for their respective Aspergillus proteins which signifies good binding and suggests that the drugs may be able to bind to the upregulated and secreted A. fumigatus proteins ( Table 2 ; Methods). Further experimental validation of these hit molecules is needed to verify whether the drug will act upon the A. fumigatus protein in the same fashion and whether the drug will have an impact upon the ability of A. fumigatus to cause aspergillosis.
Comparison of our prediction pipeline with earlier work
We have designed here a computational prediction pipeline to identify the secretome and cell membrane proteins in Aspergillus species, and the pipeline can be used for any fungi. To our knowledge, FSD 16 and FunSecKB2 17 are the only databases on pan-fungi secretome prediction.
While FSD and FunSecKB2 contain pre-computed secretome predictions for several fungal genomes, SECRETOOL 18 provides an online sever that enables implementation of a computational pipeline to predict secreted proteins among user-input protein sequences. In Supplementary Text and Supplementary Table S6 , we report a detailed comparison of the secretome predictions from our pipeline with those from FSD, FunSecKB2 and SECRETOOL.
Based on this comparative analysis with FSD, FunSecKB2 and SECRETOOL, our pipeline has following additional features. Firstly, we incorporate available experimental information from high-throughput studies and UniProt on secreted proteins (Branch A in Figure   1 ). Secondly, we incorporate and prioritize UniProt annotations with experimental evidence for presence of signal peptide, GPI anchor or TM domain in a protein sequence over bioinformatic prediction tools (Branch B in Figure 1 ). Thirdly, we provide a sub-classification of the secreted extracellular proteins into those sorted by classical pathway and those transported via nonclassical pathways. Fourthly, we have used an alternate approach whereby orthologs to secreted proteins with experimental evidence in other fungi is used to predict secretion via non-classical pathways (Branch C in Figure 1 ). We remark that our pipeline predicts a much smaller set of secreted proteins via non-classical pathways (albeit with much higher confidence) in comparison to FSD which uses SecretomeP 74,75 , a tool designed for bacteria and mammals rather than fungi.
Lastly, to our knowledge, this is the first study to perform a comparative analysis of both secreted and cell membrane proteins across Aspergillus species causing aspergillosis.
Conclusions
Aspergillosis is a serious concern among immune-compromised patients worldwide. 
Methods

Protein sequences and associated annotations for Aspergillus species
The proteomes of A. fumigatus Af293, A. niger CBS 513. 88 (http://ensemblgenomes.org/), respectively. Note that the A. ustus 3.3904 genome sequence is still incomplete, and thus, its incomplete proteome was used here for predictions.
Experimentally identified secreted proteins
We performed an extensive literature search to compile 46 published high-throughput experimental studies which have characterized the secretome of 6 Aspergillus species studied here ( Supplementary Table S1 ). Note that protein identifiers in these experimental studies for the reference strain or other strains of the same Aspergillus species were mapped to standard identifiers in the reference sequence using OrthoMCL 84 (http://orthomcl.org/orthomcl/) with inflation option set at 1.5. In addition to high-throughput studies, experimentally verified secreted or cell membrane proteins in Aspergillus species were retrieved from UniProt 19 (http://www.uniprot.org/) by filtering proteins with subcellular localization as extracellular or cell membrane, respectively, with evidence code of ECO:0000269. Note that ECO:0000269 corresponds to manually curated information with published experimental evidence. Similarly, experimentally verified secreted proteins in all other fungal species were retrieved from UniProt 19 by filtering proteins with subcellular localization as extracellular with evidence code of ECO:0000269. OrthoMCL 84 with inflation option set at 1.5 was used to identify orthologs of experimentally verified secreted proteins in other fungi in Aspergillus species.
Bioinformatic-based predictions
The following computational tools were employed to predict protein-based features in our secretome prediction pipeline. The presence of a signal peptide in the N-terminus was predicted using SignalP 4.1 106 Importantly, UniProt 19 annotations with published experimental evidence (ECO:0000269) for the protein-based features were also retrieved for Aspergillus proteins. UniProt identifiers for Aspergillus proteins were mapped to reference sequence identifiers using pre-existing maps from AspGD 103 , UniProt 19 , and in-house python scripts.. While combining information from different sources to decide on the presence of signal peptide or GPI anchor or TM domain, a decision is made based on tool predictions using an inclusive rule if UniProt annotation is not available, else decision is made only on UniProt annotation by overriding tool predictions. While combining information from different sources to decide on subcellular localization, the decision is made based on tool predictions using a majority rule if UniProt annotation is not available, else decision is made only on UniProt annotation by overriding tool predictions. Thus, our pipeline gives precedence to published experimental evidence over bioinformatic-based predictions. Supplementary Table S2 contains tool-based predictions and UniProt annotations for secreted and cell membrane proteins in Aspergillus species.
Functional annotation of secreted proteins
The predicted secretomes in Aspergillus species were annotated with information on protein family from Pfam 116 Supplementary Table S3 contains detailed annotations for secreted and cell membrane proteins in Aspergillus species.
Identification of small secreted and effector-like proteins
In the predicted secretomes of Aspergillus species, SSPs were defined as those with sequence length less than or equal to 300 amino acid residues 21, 82, 131 . The SSPs were then 16 evaluated for effector-like properties based on their EffectorP 81 (http://effectorp.csiro.au/) predictions or cysteine-richness. For identifying effector-like SSPs, cysteine-rich sequences are those which contain at least 4 cysteine residues and have greater than 5% of their total amino acid residues as cysteines 20, 132 . The predicted SSPs in the secretomes of Aspergillus species were also scanned for known fungal or oomycetes effector motifs 80 Table S4 ).
Antigenicity of secreted proteins
Antigenic regions in Aspergillus proteins were predicted using Kolaskar-Tongaonkar 90 method implemented in EMBOSS package 134 Figure 6 ). To test whether the computed average AAR values for the set of secreted and cell membrane proteins, respectively, were significantly different from the average AAR value for the whole proteome of the same species, a p-value was computed by comparing against the average AAR values for 1000 equally-sized sets of randomly drawn proteins from the complete proteome of the organism. To test whether the average AAR value for the set of secreted proteins is significantly different from that of the set of cell membrane proteins of an Aspergillus species, Wilcoxon rank-sum test was performed to compare the two sets of different sizes ( Figure 6 ).
Identification of candidate drug targets in secreted proteins
A microarray dataset for A. fumigatus Af293 from infected murine lungs 26 was obtained from Array Express (Accession number E-TABM-327). The microarray dataset from infected murine lungs 26 gave a reliable signal for 9121 genes in A. fumigatus Af293 which covers more than 90% of the secretome and 88% of the cell membrane proteins in the fungus. Gene expression data 26 Filtered proteins in A. fumigatus Af293 with significant structural similarity to known drug target proteins were subsequently tested for binding by the respective drug.
The ligand binding pockets in the protein structure model for the filtered proteins in A.
fumigatus Af293 were predicted using metaPocket 2.0 101 (http://projects.biotec.tudresden.de/metapocket/). For docking drugs to the predicted protein pockets, both protein and drug molecule were prepared by adding explicit hydrogen atoms and cleaned up using python scripts 136 , prepare_receptor4 .py and prepare_ligand4.py, with the default option. AutoDock Vina 102 (http://vina.scripps.edu/) was used for docking the drug against the predicted pockets in proteins with the option for exhaustiveness set at 24 to obtain consistent results 137 . Lastly, the binding affinity results obtained by docking drugs to the protein pockets from AutoDock Vina 102 were tabulated (Table 2) .
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In this table, we have also included information on UniProt annotations with published experimental evidence, predictions from different computational tools, and Abundance of Antigenic Regions (AAR) score for each protein.
Supplementary Table S3 : Functional annotation of identified secreted proteins and cell membrane proteins in different Aspergillus species. Supplementary Table S6 : Comparison of secretome predictions from our computational pipeline in Aspergillus species with predictions from earlier work. In the first sheet, we list the subset of Aspergillus species considered here for which FSD and FunSecKB2 have predictions in their database. In the second sheet, we compare the bioinformatic tools employed in our prediction pipeline with those in FSD, FunSecKB2 and SECRETOOL. In the third sheet, we compare predictions from our pipeline with those from FSD. In the fourth sheet, we compare predictions from our pipeline with those from FunSecKB2. In the fifth sheet, we compare predictions from our pipeline with those from SECRETOOL. 
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